| 标题 |
MLN4924 suppresses pancreatic cancer progression and enhances chemosensitivity to gemcitabine by targeting the PTGS2/EGFR-PI3K/Akt/mTOR signaling axis |
| 网址 | |
| DOI |
10.1097/cad.0000000000001838
doi
|
| 其它 |
期刊:Anti-cancer drugs 作者:Wang M; Mou Y; Qiu JY; He XF; Tang C; et al 出版日期:2026/08/11 |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)